Theacrine protects against nonalcoholic fatty liver disease by regulating acylcarnitine metabolism.
Sign Up to like & getrecommendations! Published in 2018 at "Metabolism: clinical and experimental"
DOI: 10.1016/j.metabol.2018.04.011
Abstract: OBJECTIVE Acylcarnitine metabolism disorder contributes significantly to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). There are, however, few ideal medications for NAFLD, which work by targeting acylcarnitine metabolism. The aim of this study was… read more here.
Keywords: fatty liver; metabolism; liver disease; theacrine ... See more keywords